Oxford, J. S. (John Sidney)
Oxford, John.
John Oxford British virologist (born 1942)
Oxford, John Sidney, 1942-
Oxford, J. S
Oxford, John, 19..-....
Oxford, J. S. (1942- )
Oxford, John S.
Oxford, John S. 1942-
Oxford, John S. (John Sidney), Virologie
Oxford, John Sidney
Oxford, J. S. (John Sidney), 1942-
VIAF ID: 76377030 (Personal)
Permalink: http://viaf.org/viaf/76377030
Preferred Forms
-
100 0 _ ‡a John Oxford ‡c British virologist (born 1942)
-
-
100 1 _ ‡a Oxford, J. S
-
-
-
100 1 _ ‡a Oxford, J. S. ‡q (John Sidney)
-
100 1 _ ‡a Oxford, J. S. ‡q (John Sidney)
-
-
-
-
-
-
100 1 _ ‡a Oxford, John S. ‡d 1942-
-
-
-
-
100 1 _ ‡a Oxford, John, ‡d 19..-....
-
4xx's: Alternate Name Forms (28)
Works
Title | Sources |
---|---|
1918 influenza pandemic caused by highly conserved viruses with two receptor-binding variants. |
![]() |
Aids and aids-related infections current strategies for prevention and therapy |
![]() ![]() ![]() ![]() |
Animal models in influenza vaccine testing. |
![]() |
The burden of influenza B: a structured literature review |
![]() |
Chemoprophylaxis and virus infections of the respiratory tract |
![]() ![]() ![]() |
Chemotherapy and control of influenza |
![]() |
Chemotherapy of herpes simplex virus infections |
![]() ![]() |
Clinical, scientific and ethnographic studies of influenza in quarantine |
![]() |
Comparing influenza and RSV viral and disease dynamics in experimentally infected adults predicts clinical effectiveness of RSV antivirals. |
![]() |
Conquest of viral diseases, 1985:CIP t.p. (John S. Oxford) |
![]() |
Conquest of viral diseases : a topical review of drugs and vaccines |
![]() ![]() ![]() ![]() ![]() |
Correlation between human leukocyte antigen class II alleles and HAI titers detected post-influenza vaccination |
![]() |
The current threat of avian influenza A is real and not a mirage. |
![]() |
The Determinants of Reported Personal and Household Hygiene Behaviour: A Multi-Country Study |
![]() |
DNA vaccination protects against an influenza challenge in a double-blind randomised placebo-controlled phase 1b clinical trial |
![]() |
Effectiveness of H1N1 vaccination in Scotland, UK. |
![]() |
The elephant man, c1999: |
![]() |
Factors influencing inappropriate antibiotic prescription in Europe |
![]() |
Flu: Effect of Vaccine in Elderly Care Home Residents: A Randomized Trial |
![]() |
Functional and antigenic analyses of the 1918 influenza virus haemagglutinin using a recombinant vaccinia virus expression system. |
![]() |
Human genetics and responses to influenza vaccination: clinical implications |
![]() |
Human microbial challenge: the ultimate animal model |
![]() |
Human virology |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
Immunogold electron microscopy recognizes prion protein-associated particles prepared from scrapie-infected mouse brain |
![]() |
Influenza A: a threatening virus with two faces. |
![]() |
Influenza Surveillance |
![]() |
Intranasal H5N1 vaccines, adjuvanted with chitosan derivatives, protect ferrets against highly pathogenic influenza intranasal and intratracheal challenge |
![]() |
Lack of evidence for complete resistance of peripheral blood mononuclear cells to HIV-1 and HIV-2 infection |
![]() |
Low pH gel intranasal sprays inactivate influenza viruses in vitro and protect ferrets against influenza infection. |
![]() |
Meeting report: risk assessment of tamiflu use under pandemic conditions. |
![]() |
Modification of pH Conferring Virucidal Activity on Dental Alginates |
![]() |
More action, less resistance: report of the 2014 summit of the Global Respiratory Infection Partnership |
![]() |
New antiviral drugs, vaccines and classic public health interventions against SARS coronavirus |
![]() |
New millennium antivirals against pandemic and epidemic influenza: the neuraminidase inhibitors. |
![]() |
A new millennium conundrum: how to use a powerful class of influenza anti-neuraminidase drugs (NAIs) in the community |
![]() |
The next pandemic |
![]() |
Non-responders to egg grown influenza vaccine seroconvert after booster immunization with MDCK cell grown vaccine. |
![]() |
Oseltamivir in the management of influenza. |
![]() |
Pharmaceutical interventions for mitigating an influenza pandemic: modeling the risks and health-economic impacts. |
![]() |
Pre-existing immunity in human challenge studies of influenza transmission – Authors' reply |
![]() |
Preclinical evaluation of a replication-deficient intranasal DeltaNS1 H5N1 influenza vaccine |
![]() |
Preclinical in vitro activity of QR-435 against influenza A virus as a virucide and in paper masks for prevention of viral transmission |
![]() |
Preexisting influenza-specific CD4+ T cells correlate with disease protection against influenza challenge in humans |
![]() |
Preliminary assessment of the efficacy of a T-cell-based influenza vaccine, MVA-NP+M1, in humans |
![]() |
Preparing for the first influenza pandemic of the 21st century. |
![]() |
Prescriber and Patient Responsibilities in Treatment of Acute Respiratory Tract Infections — Essential for Conservation of Antibiotics. |
![]() |
The prevalence of myocarditis and skeletal muscle injury during acute viral infection in adults: measurement of cardiac troponins I and T in 152 patients with acute influenza infection |
![]() |
Problems of antiviral therapy |
![]() ![]() ![]() ![]() |
Strong local and systemic protective immunity induced in the ferret model by an intranasal virosome-formulated influenza subunit vaccine. |
![]() |
The survival of influenza A(H1N1)pdm09 virus on 4 household surfaces. |
![]() |
A Synthetic Influenza Virus Vaccine Induces a Cellular Immune Response That Correlates with Reduction in Symptomatology and Virus Shedding in a Randomized Phase Ib Live-Virus Challenge in Humans. |
![]() |
The threat of avian influenza H5N1: 'do we have the tools for the job'? |
![]() |
A throat lozenge containing amyl meta cresol and dichlorobenzyl alcohol has a direct virucidal effect on respiratory syncytial virus, influenza A and SARS-CoV |
![]() |
Towards a universal influenza vaccine: volunteer virus challenge studies in quarantine to speed the development and subsequent licensing |
![]() |
Unanswered questions about the 1918 influenza pandemic: origin, pathology, and the virus itself |
![]() |
Use of a human influenza challenge model to assess person-to-person transmission: proof-of-concept study. |
![]() |
A view from the virology research laboratory |
![]() |
Viral load drives disease in humans experimentally infected with respiratory syncytial virus |
![]() |
Virus-specific antibody secreting cell, memory B-cell, and sero-antibody responses in the human influenza challenge model. |
![]() |
Wirusologia : podręcznik dla studentów medycyny, stomatologii i mikrobiologii |
![]() ![]() |
Would you volunteer to be quarantined and infected with influenza virus? |
![]() |